title: Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.
abstract: Low-grade gliomas are the commonest brain tumor in children comprising heterogeneous pathological entities. Though the overall prognosis is good, unresectable, and recurrent or progressive tumors in eloquent areas of the brain remain major therapeutic challenge even with advances in chemotherapeutic strategies. With the evolving surge of molecular data, improved understanding of the biology of these tumors is now perceivable that could provide insights into novel therapies. We hope the new era will enable us to profile comprehensive histopathological/molecular classification and prognostic molecular markers in these tumors and guide us to tailor optimal targeted therapy.
authors.affiliation: Pediatric Neuro-Oncology, Children's Cancer Hospital, MD Anderson Cancer Center, Unit 87, 1515 Holcombe Boulevard, Houston, TX, 77030, USA, skhatua@mdanderson.org.
authors.forename: Soumen
authors.initials: S
authors.lastname: Khatua
authors.forename: Jason
authors.initials: J
authors.lastname: Wang
authors.forename: Veena
authors.initials: V
authors.lastname: Rajaram
mesh_terms: D014408:Biomarkers, Tumor; D001932:Brain Neoplasms / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D002648:Child; D005910:Glioma / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D006801:Humans; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor